[关键字]Q?/font> Cephalosporin
Bulk
Drug
Industry
Report
健康|讯Q?/FONT>
Research Report on Chinese Bulk Cephalosporin Industry
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$6,700
Contact: Mr. Bian chenghua Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68012929-2008
E-mail: bianch@healthoo.com wuhf@healthoo.com
http://www.qzsdqp.com
Directory
1、Industry scale of China's chemical API
1.1 Basic situation and product structure of chemical API
1.2 Developing trend of chemical API lately years
1.3 Output structure of 24 Categories of chemical API last year
1.4 Output and production value of chemical API in differnet provinces
1.5 Output and share of antibiotic bulk drugs
2 Overview of antibiotic bulk drugs
2.1 Categories
2.2 Therapeutic mechanisms
2.3 Cephalosporin nucleus series
2.4 Product structure
3 7-ACA series
3.1 About 7-ACA
3.1.1 Output,production capacityQstatus of import and export,key
enterprises
3.1.2 Price trend
3.1.3 Trend of import and export
3.1.4 Connections of 7-ACA with lower-stream product
3.1.5 Market forecast
3.2 Analysis about Cefazolin
3.2.1 Output,production capacityQstatus of import and export,key
enterprises
3.2.2 Price trend
3.2.3 Market forecast
3.2.4 Connections of Cefazolin with lower-stream product
3.3 Analysis about Ceftriaxone
3.3.1 Output,production capacityQstatus of import and export,key
enterprises
3.3.2 Price trend
3.3.3 Connections of Ceftriaxone with lower-stream product
3.3.4 Market forecast
3.3.5 Export trend
3.4 Analysis about Cefoperazone
3.4.1 Output,production capacityQstatus of import and export,key
enterprises
3.4.2 Price trend
3.4.3 Status of production and sales and Market forecast
3.4.4 Connections of Cefoperazone with lower-stream product
3.4.5 Export trend
3.5 Analysis about Cefotaxime
3.5.1 Output,production capacity,key enterprises
3.5.2 Price trend
3.5.3 Export status
3.5.4 Status of production and sales and Market forecast
3.5.5 Connections of Cefotaxime with lower-stream product
3.6 Analysis about Ceftazidime
3.6.1 Output,production capacityQstatus of import and export,key
enterprises
3.6.2 Price trend
3.6.3 Connections of Ceftazidime with lower-stream product
3.6.4 Status of production and sales and Market forecast
3.7 Analysis about Ceftazidime
3.7.1 Output,production capacity,key enterprises
3.7.2 Price trend and import & export
3.7.3 Status of production and sales and Market forecast
4 7-ADCA series
4.1 Output,production capacity,enterprise's share
4.1.1 Output,production capacityQstatus of import and export,key
enterprises
4.1.2 Price trend
4.1.3 Connections of 7-ADCA with lower-stream product
4.1.4 Status of production and sales and Market forecast
4.2 Cefalexin
4.2.1 Output,production capacityQstatus of import and export,key
enterprises
4.1.2 Price trend
4.2.3 Connections of Cefalexin with lower-stream product
4.2.4 Connections of Cefalexin with lower-stream product
4.3 Cefradine
4.3.1 Output,production capacityQstatus of import and export,key
enterprises
4.3.2 Price trend
4.3.3 Status of production and sales and Market forecast
4.3.4 Connections of Cefradine with lower-stream product
4.4 Cefadroxil
4.4.1 Output,production capacityQstatus of import and export,key
enterprises
4.4.2 Price trend
4.4.3 Status of production and sales and Market forecast
4.4.4 Connections of Cefradine with lower-stream product
4.5 Other antibiotic bulk drugs
5 About key enterprise
5.1 Shijiazhuang Pharmaceutical Group Co.,Ltd
5.2 Shandong Lukang Pharmaceutical Group Co.,Ltd
5.3 Fujian antibiotic Pharmaceutical Co.,Ltd
5.4 Suzhou Dongrui Pharmaceutical Co.,Ltd
5.5 Zhuhai Federal Pharmaceutical Company, Ltd
5.6 Shandong xinhua-chemfermPharmaceutical Co., Ltd
5.7 North China pharmaceutical Group Corporation
5.8 Harbin General Pharmaceutical Factory
5.9 Zhejiang Yongning Pharmaceutical Factory
5.10 Guangzhou Baiyunshan Pharmaceutical Co., Ltd